Compounds > 3,3,5,5-tetramethyl-1-pyrroline n-oxide
Page last updated: 2024-09-04

3,3,5,5-tetramethyl-1-pyrroline n-oxide and Carcinoma, Epidermoid

3,3,5,5-tetramethyl-1-pyrroline n-oxide has been researched along with Carcinoma, Epidermoid in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Hou, Y; Tian, F; Zhang, C; Zhang, L; Zhang, Y1

Other Studies

1 other study(ies) available for 3,3,5,5-tetramethyl-1-pyrroline n-oxide and Carcinoma, Epidermoid

ArticleYear
TMPO-AS1 is an independent prognostic factor for patients with laryngeal squamous cell carcinoma.
    Revista da Associacao Medica Brasileira (1992), 2020, Volume: 66, Issue:6

    Topics: Carcinoma, Squamous Cell; Cyclic N-Oxides; Humans; Laryngeal Neoplasms; Prognosis; RNA, Long Noncoding; Thymopoietins

2020